Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carol A Mercer

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2010
Differences in wound healing in mice with deficiency of IL-6 versus IL-6 receptorMolly M McFarland-Mancini, Holly M Funk, Andrew M Paluch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2018
Phenformin-Induced Mitochondrial Dysfunction Sensitizes Hepatocellular Carcinoma for Dual Inhibition of mTORSónia R Veiga, Xuemei Ge, Carol A Mercer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2014
A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium ReportMaryam Fouladi, John P Perentesis, Lars M Wagner, et al.
Autophagy|January 24, 2020
Mass spectrometry proteomics reveals a function for mammalian CALCOCO1 in MTOR-regulated selective autophagyJonathan A Stefely, Yu Zhang, Elyse C Freiberger, et al.
Targeted Oncology|March 31, 2017
A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid MalignanciesTrisha M Wise-Draper, Ganesh Moorthy, Mohamad A Salkeni, et al.
Molecular Cancer Therapeutics|September 3, 2017
mTOR Kinase Inhibition Effectively Decreases Progression of a Subset of Neuroendocrine Tumors that Progress on Rapalog Therapy and Delays Cardiac ImpairmentMelissa A Orr-Asman, Zhengtao Chu, Min Jiang, et al.
Blood|January 29, 2021
Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma deathAna Domostegui, Suresh Peddigari, Carol A Mercer, et al.
Science Translational Medicine|April 28, 2012
mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinomaHala Elnakat Thomas, Carol A Mercer, Larissa S Carnevalli, et al.
Nature Communications|September 12, 2018
Hepatic Ago2-mediated RNA silencing controls energy metabolism linked to AMPK activation and obesity-associated pathophysiologyCai Zhang, Joonbae Seo, Kazutoshi Murakami, et al.
Autophagy|September 12, 2012
Guidelines for the use and interpretation of assays for monitoring autophagyDaniel J Klionsky, Fabio C Abdalla, Hagai Abeliovich, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2010
Differences in wound healing in mice with deficiency of IL-6 versus IL-6 receptorMolly M McFarland-Mancini, Holly M Funk, Andrew M Paluch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 26, 2018
Phenformin-Induced Mitochondrial Dysfunction Sensitizes Hepatocellular Carcinoma for Dual Inhibition of mTORSónia R Veiga, Xuemei Ge, Carol A Mercer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 4, 2014
A Phase I Study of Cixutumumab (IMC-A12) in Combination with Temsirolimus (CCI-779) in Children with Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium ReportMaryam Fouladi, John P Perentesis, Lars M Wagner, et al.
Autophagy|January 24, 2020
Mass spectrometry proteomics reveals a function for mammalian CALCOCO1 in MTOR-regulated selective autophagyJonathan A Stefely, Yu Zhang, Elyse C Freiberger, et al.
Targeted Oncology|March 31, 2017
A Phase Ib Study of the Dual PI3K/mTOR Inhibitor Dactolisib (BEZ235) Combined with Everolimus in Patients with Advanced Solid MalignanciesTrisha M Wise-Draper, Ganesh Moorthy, Mohamad A Salkeni, et al.
Molecular Cancer Therapeutics|September 3, 2017
mTOR Kinase Inhibition Effectively Decreases Progression of a Subset of Neuroendocrine Tumors that Progress on Rapalog Therapy and Delays Cardiac ImpairmentMelissa A Orr-Asman, Zhengtao Chu, Min Jiang, et al.
Blood|January 29, 2021
Impaired ribosome biogenesis checkpoint activation induces p53-dependent MCL-1 degradation and MYC-driven lymphoma deathAna Domostegui, Suresh Peddigari, Carol A Mercer, et al.
Science Translational Medicine|April 28, 2012
mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinomaHala Elnakat Thomas, Carol A Mercer, Larissa S Carnevalli, et al.
Nature Communications|September 12, 2018
Hepatic Ago2-mediated RNA silencing controls energy metabolism linked to AMPK activation and obesity-associated pathophysiologyCai Zhang, Joonbae Seo, Kazutoshi Murakami, et al.
Autophagy|September 12, 2012
Guidelines for the use and interpretation of assays for monitoring autophagyDaniel J Klionsky, Fabio C Abdalla, Hagai Abeliovich, et al.
Pageof 2